Reardon Andrew Insider Trading Activity
Reardon Andrew has been net-selling over the last 12 months with 0 purchases and 31 sales across 1 company.
LGND is the most-traded position with 31 trades. The largest single transaction was a sale of LGND for $349K on Jul 1, 2026.
Performance Scorecard
Forward stock performance after each transaction by Reardon Andrew. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.3% | 38% | 26 |
| 90 days | — | -33.4% | 0% | 19 |
| 120 days | — | -57.8% | 0% | 13 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersLGND · LIGAND PHARMACEUTICALS INC
🔒 Subscribe to see trade entries
Pro members see exactly when Reardon Andrew bought and sold LGND.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 1, 2026 Filed 3d late | LGND | Sell | 900 | $315.78 | $284K | −2.1% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 100 | $314.58 | $31K | −0.2% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 700 | $313.46 | $219K | −1.6% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 1,081 | $312.28 | $338K | −2.4% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 1,119 | $311.72 | $349K | −2.4% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 104 | $310.20 | $32K | −0.2% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 396 | $308.99 | $122K | −0.9% | CLO & Secretary | |
Jul 1, 2026 Filed 3d late | LGND | Sell | 600 | $317.15 | $190K | −1.4% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 600 | $227.45 | $136K | −1.3% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 932 | $228.75 | $213K | −2.0% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 98 | $229.71 | $23K | −0.2% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 370 | $230.87 | $85K | −0.8% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 780 | $232.04 | $181K | −1.8% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 1,420 | $232.92 | $331K | −3.3% | CLO & Secretary | |
May 1, 2026 | LGND | Sell | 800 | $234.02 | $187K | −1.9% | CLO & Secretary | |
Apr 1, 2026 | LGND | Sell | 1,238 | $200.94 | $249K | −2.8% | CLO & Secretary | |
Apr 1, 2026 | LGND | Sell | 460 | $198.85 | $91K | −1.0% | CLO & Secretary | |
Apr 1, 2026 | LGND | Sell | 1,302 | $199.72 | $260K | −2.8% | CLO & Secretary | |
Apr 1, 2026 | LGND | Sell | 337 | $204.50 | $69K | −0.8% | CLO & Secretary | |
Apr 1, 2026 | LGND | Sell | 963 | $203.22 | $196K | −2.3% | CLO & Secretary | |
Apr 1, 2026 | LGND | Sell | 700 | $201.90 | $141K | −1.6% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 1,446 | $208.12 | $301K | −3.7% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 1,142 | $208.87 | $239K | −3.0% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 207 | $199.96 | $41K | −0.5% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 100 | $197.70 | $20K | −0.2% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 93 | $200.62 | $19K | −0.2% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 300 | $201.70 | $61K | −0.7% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 200 | $204.17 | $41K | −0.5% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 460 | $205.18 | $94K | −1.1% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 340 | $206.37 | $70K | −0.8% | CLO & Secretary | |
Mar 4, 2026 | LGND | Sell | 612 | $207.01 | $127K | −1.5% | CLO & Secretary | |
Jun 23, 2025 | LGND | Sell | 500 | $114.08 | $57K | −1.5% | CLO & Secretary | |
Jun 10, 2025 | LGND | Sell | 500 | $114.54 | $57K | −1.5% | CLO & Secretary | |
May 15, 2025 ⚠ Filed 12d late | LGND | Sell | 1,000 | $104.00 | $104K | −2.9% | CLO & Secretary |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | 34 | $5.0M |
Other insiders at LIGAND PHARMACEUTICALS INC
5 other tracked filers at LGND.